Clinical trial Recruiting at 1 site Observational Ages 18 and up

Long-Term safety and performance of the IntraSPINE interlaminar implant for degenerative lumbar spine disease

Official title: Long-Term Evaluation of the Performance and Safety of the IntraSPINE® Interlaminar Implant in the Treatment of Lumbar Degenerative Disc Disease

Run by Cousin Biotech · NCT07790328 · Data updated 2026-11-12

This study follows up patients who previously received IntraSPINE implants to see how their symptoms and imaging look about 9 years later.

More Spinal Disease trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorCousin Biotech
Industry-sponsored
Locations1 site (Saran)
StatusRecruiting
StartedJuly 28, 2020
Main results expectedJune 1, 2026
Study endsJune 1, 2031
Registry record updatedAugust 27, 2026
Trial IDNCT07790328 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with degenerative lumbar disc disease at one or two levels who were indicated for IntraSPINE implantation after conservative treatment failed.

Probably not a fit

Patients whose condition does not improve or worsens over time or those with contraindications may derive no clear benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational extension study tracking patients who had the IntraSPINE implant for degenerative lumbar spine conditions. It recontacts about 50 participants from an earlier trial (2012–2017) to collect long-term clinical and radiological data, including MRI findings. The goal is to understand long-term safety and performance of the implant in real-world follow-up. Participants are adults who had one or two lumbar levels treated after conservative care failed, with assessment ongoing at least 9 years post-implant. The study design does not assign treatment randomized groups and focuses on extended observation.

Why it matters

Potential benefit: If successful, results could clarify long-term safety and durability of the IntraSPINE implant for chronic lumbar spine conditions.

How similar studies have gone: Previous prospective work suggests potential for implant-based approaches, with long-term follow-up remaining limited and this study adds real-world extension data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patient,
* Patient with degenerative lumbar disc disease at one or two levels for whom
* Surgery involving the placement of an IntraSPINE® implant has been indicated following the failure of conservative treatment,
* Patient who has read and signed the information and consent form

Exclusion Criteria:

* Patients with the following contraindications:
* Allergy to any of the components,
* Infected site,
* Pregnant women.
* Patients with spondylolisthesis with isthmic lysis

Where it's running

  • Maison des consultations
    Saran, France
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.